Literature DB >> 7083739

NMR imaging of the brain using spin-echo sequences.

D R Bailes, I R Young, D J Thomas, K Straughan, G M Bydder, R E Steiner.   

Abstract

Eight normal volunteers and 32 patients with a variety of neurological disease were studied with a nuclear magnetic resonance (NMR) scanner using repeated free induction decay (RFID), inversion-recovery (IR) and spin-echo (SE) sequences. The results were compared with X-ray computed tomography (CT). RFID sequences which produce images that reflect changes in proton density displayed very little grey-white matter contrast and relatively small changes in disease. IR sequences which produce images that are dependent on T1 showed a high level of grey-white matter contrast and demonstrated changes in a variety of pathological processes. Although SE scans, which have a strong T2 dependence, had shown no abnormality in previous studies of patients with neurological disease, sequences of this type with longer values of tau displayed abnormalities in cerebral infarction, haemorrhage, herpes encephalitis, multiple sclerosis, cerebral oedema, hydrocephalus, tumours and Wilson's disease. All of these conditions were associated with an increase in T2. Abnormalities were demonstrated in cases of multiple sclerosis and brainstem infarction with NMR scans where no abnormality was seen with CT. More extensive changes were seen with NMR in cases of hemisphere infarction, systemic lupus erythematosis, herpes encephalitis, hydrocephalus (periventricular oedema) and Sturge-Weber disease. The margin between malignant tumour and surrounding oedema was better defined with contrast enhanced CT in four of eight malignant tumours, equally well defined in one, and better defined with NMR in three cases. NMR spin-echo sequences provide a sensitive technique for detecting abnormalities in a variety of neurological disease.

Entities:  

Mesh:

Year:  1982        PMID: 7083739     DOI: 10.1016/s0009-9260(82)80307-3

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  13 in total

1.  Review. The Agfa Mayneord lecture: MRI of short and ultrashort T₂ and T₂* components of tissues, fluids and materials using clinical systems.

Authors:  G M Bydder
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

2.  Nuclear magnetic resonance of the brain.

Authors:  G M Bydder
Journal:  Cardiovasc Intervent Radiol       Date:  1986       Impact factor: 2.740

Review 3.  Pulse sequences as tissue property filters (TP-filters): a way of understanding the signal, contrast and weighting of magnetic resonance images.

Authors:  Ian R Young; Nikolaus M Szeverenyi; Jiang Du; Graeme M Bydder
Journal:  Quant Imaging Med Surg       Date:  2020-05

4.  Magnetic resonance imaging. Part II--Clinical applications.

Authors:  W R Hendee; C J Morgan
Journal:  West J Med       Date:  1984-11

5.  Nuclear magnetic resonance imaging of the brain.

Authors:  G M Bydder; A Whitelaw
Journal:  Arch Dis Child       Date:  1983-06       Impact factor: 3.791

6.  Nuclear magnetic resonance and its applications in medicine.

Authors:  K D Moudgil; D N Rao; B S Narang
Journal:  Indian J Pediatr       Date:  1985 May-Jun       Impact factor: 1.967

7.  Nuclear magnetic resonance imaging of the brain in children.

Authors:  M I Levene; A Whitelaw; V Dubowitz; G M Bydder; R E Steiner; C P Randell; I R Young
Journal:  Br Med J (Clin Res Ed)       Date:  1982-09-18

Review 8.  Susceptibility-weighted imaging: technical aspects and clinical applications, part 1.

Authors:  E M Haacke; S Mittal; Z Wu; J Neelavalli; Y-C N Cheng
Journal:  AJNR Am J Neuroradiol       Date:  2008-11-27       Impact factor: 3.825

9.  Magnetic resonance imaging of the child's brain.

Authors:  B L Hershey; R A Zimmerman
Journal:  Childs Nerv Syst       Date:  1986       Impact factor: 1.475

10.  Spin-echo MR imaging of intracranial hemorrhage.

Authors:  G C Dooms; A Uske; M Brant-Zawadzki; W Kucharczyk; L Lemme-Plaghos; T H Newton; D Norman
Journal:  Neuroradiology       Date:  1986       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.